Latest Investment Trends from Fidelity Portfolio Managers · Finding companies with a competitive...
Transcript of Latest Investment Trends from Fidelity Portfolio Managers · Finding companies with a competitive...
![Page 1: Latest Investment Trends from Fidelity Portfolio Managers · Finding companies with a competitive advantage, barriers to entry, pricing power, and strong management should deliver](https://reader030.fdocuments.net/reader030/viewer/2022040401/5e7c6119814fea1a007ba7d2/html5/thumbnails/1.jpg)
July 24, 2019
Latest Investment Trends from
Fidelity Portfolio Managers
Chris Lin
Portfolio Manager
Eddie Yoon
Sector Leader/Portfolio Manager
![Page 2: Latest Investment Trends from Fidelity Portfolio Managers · Finding companies with a competitive advantage, barriers to entry, pricing power, and strong management should deliver](https://reader030.fdocuments.net/reader030/viewer/2022040401/5e7c6119814fea1a007ba7d2/html5/thumbnails/2.jpg)
Background and Investment Philosophy
![Page 3: Latest Investment Trends from Fidelity Portfolio Managers · Finding companies with a competitive advantage, barriers to entry, pricing power, and strong management should deliver](https://reader030.fdocuments.net/reader030/viewer/2022040401/5e7c6119814fea1a007ba7d2/html5/thumbnails/3.jpg)
Portfolio Manager Profile: Christopher Lin
3
Current
Responsibilities
Previous
ResponsibilitiesTenure Education
Fidelity OTC Portfolio
2017–Present
Fidelity OTC Commingled Pool
2017–Present
Fidelity and Fidelity Advisor
Stock Selector Mid Cap Funds
Co-manager
2016–2018
Fidelity Select Computers
Portfolio
2013–2018
Fidelity Select and Fidelity
Advisor Semiconductors
Portfolio Co-manager
2009–2013
Research Analyst
2006–2017
Research Associate
2003–2006
Fidelity Investments
Since 2003
Harvard University
BA, 2003
OVER 15 YEARS of asset management experience
Source: Fidelity Investments.
![Page 4: Latest Investment Trends from Fidelity Portfolio Managers · Finding companies with a competitive advantage, barriers to entry, pricing power, and strong management should deliver](https://reader030.fdocuments.net/reader030/viewer/2022040401/5e7c6119814fea1a007ba7d2/html5/thumbnails/4.jpg)
Investment Philosophy
4
Most mispricings are a function of the market either over or underestimating the
durability of a business.
Finding companies with a competitive advantage, barriers to entry, pricing power,
and strong management should deliver superior earnings over the long term.
Still an analyst at heart; believes bottom-up, fundamental analysis is the best way
to exploit inappropriate valuations in the market.
◼
◼
◼
![Page 5: Latest Investment Trends from Fidelity Portfolio Managers · Finding companies with a competitive advantage, barriers to entry, pricing power, and strong management should deliver](https://reader030.fdocuments.net/reader030/viewer/2022040401/5e7c6119814fea1a007ba7d2/html5/thumbnails/5.jpg)
Current
Responsibilities
Previous
ResponsibilitiesTenure Education
Fidelity Select Health Care
Portfolio
2008–Present
Fidelity Advisor Health Care Fund
2008–Present
Fidelity VIP Health Care
2008–Present
Fidelity Select Medical
Technology and Devices Portfolio
2007–Present
Prior to Fidelity
Analyst/Portfolio Co-Manager, JP
Morgan
2005–2006
Analyst, JP Morgan
2002–2005
Fidelity Investments
Since 2006
Industry Experience
Since 2002
Brown University
BA, 2002
OVER 15 YEARS of asset management experience
Portfolio Manager Profile: Eddie Yoon
5
Source: Fidelity Investments.
![Page 6: Latest Investment Trends from Fidelity Portfolio Managers · Finding companies with a competitive advantage, barriers to entry, pricing power, and strong management should deliver](https://reader030.fdocuments.net/reader030/viewer/2022040401/5e7c6119814fea1a007ba7d2/html5/thumbnails/6.jpg)
6
Investment Philosophy
Stockpicking: High-quality, bottom-up fundamental research can uncover new
innovations and business trends before other market participants.
It’s All about Free Cash Flow (FCF)/share: Stock prices in the long run are a
reflection of the underlying free cash flow that is available to shareholders.
Capital Allocation Matters: A management team’s capital deployment can add or
destroy meaningful value over time.
◼
◼
◼
Source: Fidelity Investments.
![Page 7: Latest Investment Trends from Fidelity Portfolio Managers · Finding companies with a competitive advantage, barriers to entry, pricing power, and strong management should deliver](https://reader030.fdocuments.net/reader030/viewer/2022040401/5e7c6119814fea1a007ba7d2/html5/thumbnails/7.jpg)
Outlook & Themes
![Page 8: Latest Investment Trends from Fidelity Portfolio Managers · Finding companies with a competitive advantage, barriers to entry, pricing power, and strong management should deliver](https://reader030.fdocuments.net/reader030/viewer/2022040401/5e7c6119814fea1a007ba7d2/html5/thumbnails/8.jpg)
Nasdaq Composite as a BenchmarkWhile the Nasdaq has been closely correlated with the growth indices historically,
it has outperformed them over most time periods
8
ROLLING 3-YEAR CUMULATIVE
RETURNS AS OF 6/30/19
TOTAL CUMULATIVE RETURNS
AS OF 6/30/19
-100%
0%
100%
200%
300%
400%
500%
Jan-97 Jan-00 Jan-03 Jan-06 Jan-09 Jan-12 Jan-15 Jan-18
Cu
mu
lati
ve
Re
turn
S&P 500 R1000 Growth R3000 Growth NASDAQ
Source: Fidelity Investments, Factset.
Past performance is no guarantee of future results Indexes are unmanaged. It is not possible to invest directly in an index. Not intended to represent the
performance of any Fidelity fund.
0%
50%
100%
150%
200%
250%
300%
350%
400%
450%
5YR 10YR 15YR 20YR
S&P 500 R1000 Growth R 3000 Growth NASDAQ
![Page 9: Latest Investment Trends from Fidelity Portfolio Managers · Finding companies with a competitive advantage, barriers to entry, pricing power, and strong management should deliver](https://reader030.fdocuments.net/reader030/viewer/2022040401/5e7c6119814fea1a007ba7d2/html5/thumbnails/9.jpg)
9
For illustrative purposes only.
The companies mentioned here are not necessarily holdings invested in by FMR LLC. References to specific companies should not be construed as a recommendation or
investment advice. The statements and opinions are subject to change at any time, based on market and other conditions.
2020s
Machine Learning
2010s
Mobile
2000s
Web
1990s
Desktop
1970s - 1980s
Mainframe
Evolution of Technology Market Leadership
![Page 10: Latest Investment Trends from Fidelity Portfolio Managers · Finding companies with a competitive advantage, barriers to entry, pricing power, and strong management should deliver](https://reader030.fdocuments.net/reader030/viewer/2022040401/5e7c6119814fea1a007ba7d2/html5/thumbnails/10.jpg)
10
Favorable Demographics
0%
25%
1960 1970 1980 1990 2000 2010 2020 2030 2040 2050
Over
85
Over
65
HEALTH CARE SPENDING
PER CAPITA, BY AGE
Sources: Top and Bottom Left: JP Morgan, Center for Medicare and Medicaid Services, Census Bureau, as of 11/30/17.
Right chart: World Bank, as of 12/31/15.
PORTION OF U.S. POPULATION OF
A PARTICULAR AGE GROUP
$3,552 $4,458
$9,513
$16,872
$32,411
0–18 19–44 45–64 65–84 85+
Census Forecast
Aging demographics is a global phenomenon.
In the U.S., approximately 10,000 people turn 65 every day
![Page 11: Latest Investment Trends from Fidelity Portfolio Managers · Finding companies with a competitive advantage, barriers to entry, pricing power, and strong management should deliver](https://reader030.fdocuments.net/reader030/viewer/2022040401/5e7c6119814fea1a007ba7d2/html5/thumbnails/11.jpg)
Globalization of Health CareAdoption by emerging markets
11
$4,562
$313 $95 $18 $42
$9,536
$780 $524$64
$425
United States Brazil Russia India China
2000 2015
PER CAPITA TOTAL EXPENDITURE ON HEALTH (U.S.$)
What about Association
of Southeast Asian
Nations’ population of
630M+?
Source: World Bank, as of 12/31/16. Note: Data at average U.S.$ exchange rate for the year.
283%
Combined
Population
~3,100,000,000
Fast-growing emerging markets are spending a lower percent of their GDP on health care,
and per capita spending is rising quickly.
+109%
U.S
Expenditures ?
![Page 12: Latest Investment Trends from Fidelity Portfolio Managers · Finding companies with a competitive advantage, barriers to entry, pricing power, and strong management should deliver](https://reader030.fdocuments.net/reader030/viewer/2022040401/5e7c6119814fea1a007ba7d2/html5/thumbnails/12.jpg)
12
Life Cycle of a Biotechnology TherapyCapital users in first 10 years, profitable in subsequent years
Source: Fidelity Investments. For illustration purposes.
EARNINGS TRAJECTORY FROM R&D THROUGH LAUNCH
Probability of
success
is very low
44%
9%
Phase 1
Phase 3–10 0 +10 +20Tim
e (
Ye
ars
)
Earnings ($)
Regulatory–1 to 0
Launch0 to 3
Earnings Power3+
Clinical–10 to –1
![Page 13: Latest Investment Trends from Fidelity Portfolio Managers · Finding companies with a competitive advantage, barriers to entry, pricing power, and strong management should deliver](https://reader030.fdocuments.net/reader030/viewer/2022040401/5e7c6119814fea1a007ba7d2/html5/thumbnails/13.jpg)
The Future: Value-Based Medical Delivery and Payment
13
LOW HIGH
Simple. Personalized.
Focused on holistic health.
Right care at right time. Convenient access.
Face-to-face. Aligned incentives.
Cloud-
Telemedicine
HIGH LOW
Hospitals
Ambulatory Service Centers
Free-Standing ER
Retail Health/Urgent Centers
Doctors’ Offices
INTEGRATED CARE DELIVERY
Chronic Care
Programs
Specialists
PCPHouse
Hospitals
Urgent
Care
Pharmacy/Medication
Management
Labs
DENSITY
COST
Source: Blue Cross Blue Shield Texas, Humana.
Patient
![Page 14: Latest Investment Trends from Fidelity Portfolio Managers · Finding companies with a competitive advantage, barriers to entry, pricing power, and strong management should deliver](https://reader030.fdocuments.net/reader030/viewer/2022040401/5e7c6119814fea1a007ba7d2/html5/thumbnails/14.jpg)
Important Information: Market Indices
The NASDAQ Composite® Index measures all Nasdaq® domestic and international based common type stocks listed on The Nasdaq Stock Market®
(Nasdaq). This index is ordinarily
calculated without regard to cash dividends of the index securities. Oversight responsibility for the Index, including methodology, is handled by NASDAQ
OMX.
The Russell 1000 Growth Index is a market capitalization–weighted index designed to measure the performance of the large-cap
growth segment of the U.S. equity market.
The Russell 3000 Growth Index is a market-capitalization-weighted index designed to measure the performance of the broad growth segment of the
U.S. equity market. It includes those Russell 3000 Index companies with higher price-to-book ratios and higher forecasted growth rates.
The S&P 500® is a market capitalization-weighted index of 500 common stocks chosen for market size, liquidity, and industry group representation to
represent U.S. equity performance. S&P 500 is a registered service mark of The McGraw-Hill Companies, Inc., and has been licensed for use by
Fidelity Distributors Corporation and its affiliates.
14
![Page 15: Latest Investment Trends from Fidelity Portfolio Managers · Finding companies with a competitive advantage, barriers to entry, pricing power, and strong management should deliver](https://reader030.fdocuments.net/reader030/viewer/2022040401/5e7c6119814fea1a007ba7d2/html5/thumbnails/15.jpg)
Important Information
The information presented reflects the opinions of the presenter, as of 07/24/2019 and do not necessarily represent the views of Fidelity Investments.
These opinions are subject to change at any time based on market or other conditions. These materials are provided for informational purposes only
and should not be used or construed as a recommendation of any security, sector, or investment strategy. Please consult your tax or financial advisor
for additional information concerning your specific situation.
To the extent any investment information in this material constitutes a recommendation, it is not meant to be impartial investment advice or advice in a
fiduciary capacity, is not intended to be used as a primary basis for your investment decisions, is based on facts and circumstances at the point in time it
is made, and will not be updated if facts or circumstances change unless you contact Fidelity and ask for a new recommendation. Fidelity and its
representatives have a financial interest in any investment alternatives or transactions described in this material. Fidelity receives compensation from
Fidelity funds and products, certain third-party funds and products, and certain investment services. The compensation that is received, either directly or
indirectly, by Fidelity may vary based on such funds, products and services, which can create a conflict of interest for Fidelity and its representatives.
It is not possible to invest directly in an index. All market indices are unmanaged.
Stock markets, especially foreign markets, are volatile and can decline significantly in response to adverse issuer, political, regulatory, market, or
economic developments. Foreign securities are subject to interest rate, currency exchange rate, economic, and political risks. The fund may have
additional volatility because it can invest a significant portion of assets in securities of a small number of individual issuers. Past performance is no
guarantee of future results.
Fidelity Investments & Pyramid Design is a registered service mark of FMR LLC.
Third-party trademarks and service marks are the property of their respective owners. All other trademarks and service marks are the property of FMR
LLC or an affiliated company.
Before investing in any mutual fund or exchange traded product, have your client consider its investment objectives, risks, charges, and
expenses. Contact Fidelity for a prospectus, or a summary prospectus if available, containing this information. Have your client read it
carefully.
Fidelity Brokerage Services LLC, Member NYSE, SIPC, 900 Salem Street, Smithfield, RI 02917.
892597.1.0
15